Recent basic experiments and bioinformatics analyses have revealed that MLKL mRNA expression levels are dramatically lower in GC than normal tissue and that GC patients with low MLKL expression have a poorer prognosis compared to normal tissues (11). The gene discussed is MLKL; the disease is gastric cancer.